multiple

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALLEHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

EHA 2025 | Multiple Studies Report Encouraging Data of Olverembatinib in Ph+ ALL

ROCKVILLE, Md. and SUZHOU, China, June 15, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical…

2 days ago
Persistent Achieves Top Rankings for the Second Year in a Row in Extel’s Asia Executive Team SurveyPersistent Achieves Top Rankings for the Second Year in a Row in Extel’s Asia Executive Team Survey

Persistent Achieves Top Rankings for the Second Year in a Row in Extel’s Asia Executive Team Survey

Recognized under multiple categories, including Best CEO, Company Board of Directors, Overall ESG, Best Investor Relations Program, and Best Investor…

2 weeks ago
OTM recognised as the Leading Travel Trade Show in India and Asia, for the Second Year in a Row, in a custom study commissioned by Fairfest Media and conducted by NielsenIQOTM recognised as the Leading Travel Trade Show in India and Asia, for the Second Year in a Row, in a custom study commissioned by Fairfest Media and conducted by NielsenIQ

OTM recognised as the Leading Travel Trade Show in India and Asia, for the Second Year in a Row, in a custom study commissioned by Fairfest Media and conducted by NielsenIQ

The customised study, commissioned by Fairfest Media and conducted by NielsenIQ, the leader in consumer intelligence, indicated that travel industry…

2 weeks ago